Stifel cuts Curtiss-Wright target to $331, retains hold rating
Stifel analysts adjusted their outlook on Curtiss-Wright stock, reducing the price target to $331 from the previous $370 while maintaining a Hold rating. The revision follows Curtiss-Wright's release ...
Stifel maintains Buy on Iovance Biotherapeutics, target at $21
Stifel analysts maintained their Buy rating on Iovance Biotherapeutics (NASDAQ:IOVA), currently trading at $5.24, with a steady price target of $21.00. According to InvestingPro data, analyst targets ...
Stifel Introduces Stifel Discover
Proprietary Insights – Stifel Discover delivers exclusive analysis and commentary from Stifel’s Chief Investment Officer, Chief Economist, Chief Washington Policy Strategist, equity research analysts, ...